Report from Annual General Meeting of Vitrolife AB (publ)

Rhea-AI Summary

• English
• French
• German
• Italian
• Korean
• Spanish

Vitrolife AB held its Annual General Meeting, deciding on a SEK 1.00 per share dividend for 2023, re-election of board members, board remuneration details, auditor re-election, share issuance authorization, share-based incentive program, and more.

GOTHENBURG, Sweden, April 25, 2024 /PRNewswire/ --

At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:

• Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the record day.
• Re-election of Board members Henrik Blomquist, Lars Holmqvist, Pia Marions, Jón Sigurdsson and Karen Lykke Sørensen, in accordance with the election committee's proposal. Jón Sigurdsson was elected Chairman of the Board.
• Remuneration to the Board members is proposed to be in total SEK 3,300,000 of which SEK 1,200,000 to the Chairman of the Board, SEK 400,000 to each of the other members of the Board, SEK 150,000 to the Chairman of the Audit Committee and SEK 75,000 to each of the other members of the Audit Committee, SEK 100,000 to the Chairman of the Remuneration Committee and SEK 50,000 to each of the other members of the Remuneration Committee.
• The Election Committee proposes re-election of the auditor Deloitte AB for a period of three years after annual decisions and with unchanged remuneration principles.
• Authorization for the Board, for the time up until the next Annual General Meeting and on one or more occasions, to resolve to issue a maximum of 13,544,719 shares in total, corresponding to just below 10 percent of the company's share capital.
• Authorization for the Board, for the time up until the next Annual General Meeting and on one or more occasions, to resolve on acquisition of the company's own shares. The Company can at no time hold more than 10 percent of the total shares in the Company.
• Resolution to implement a share-based incentive program including issue of a maximum number of 480,000 warrants to a wholly owned subsidiary of Vitrolife AB and approval that the subsidiary may transfer shares and/or warrants and of hedging activities.

Gothenburg, April 25, 2024
VITROLIFE AB (publ)
The Board

The information was submitted for publication, through the agency of the contact persons set out above, at 25-04-2024 17:20 CET.

Contact: 
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/report-from-annual-general-meeting-of-vitrolife-ab--publ-,c3967068

The following files are available for download:

https://mb.cision.com/Main/1031/3967068/2761483.pdf

Report from Annual General Meeting of Vitrolife AB (publ)

 

View original content:https://www.prnewswire.com/news-releases/report-from-annual-general-meeting-of-vitrolife-ab-publ-302127752.html

SOURCE Vitrolife AB (publ)

FAQ

What dividend was decided for the financial year 2023 by Vitrolife AB?

Vitrolife AB decided on a dividend of SEK 1.00 per share for the financial year 2023.

Who were re-elected as board members at the Annual General Meeting of Vitrolife AB?

Board members re-elected at the Annual General Meeting of Vitrolife AB include Henrik Blomquist, Lars Holmqvist, Pia Marions, Jón Sigurdsson, and Karen Lykke Sørensen.

What is the total remuneration proposed for the board members of Vitrolife AB?

The proposed total remuneration for board members of Vitrolife AB is SEK 3,300,000, with varying amounts for different roles.

Which auditor was proposed for re-election by the Election Committee at the Annual General Meeting?

The Election Committee proposed re-election of Deloitte AB as the auditor of Vitrolife AB.

What authorization was given to the Board regarding share issuance at the Annual General Meeting?

The Board was authorized to issue a maximum of 13,544,719 shares, representing just below 10 percent of the company's share capital.

What share-based incentive program was approved at the Annual General Meeting of Vitrolife AB?

A share-based incentive program including the issuance of a maximum of 480,000 warrants to a wholly owned subsidiary of Vitrolife AB was approved.